Navigation Links
CoolTouch Inc. Settles Diomed Lawsuit, Files Re-examination Request for Cynosure '873 Patent
Date:4/13/2009

assisted lipolysis. These new patent applications are continuations-in-part of issued patent No. 7,217,265 filed in May 2005, and cover laser lipolysis devices such as thermal sensing, suction handpieces and placement of the fiber optic in direct contact with the tissue.

About CoolTouch

CoolTouch Inc. is a leading U.S.-based developer and manufacturer of innovative, advanced laser products for medical professionals. Engineering and science-based, CoolTouch is considered a pioneer in the medical and aesthetics technology industry. In 1994, CoolTouch introduced the first 1320 nm wavelength laser to medical professionals for non-ablative wrinkle treatment. CoolTouch continued to set new standards in the industry with the launch of CoolTouch CTEV in 2004 for varicose vein treatment and with CoolLipo for laser lipolysis and skin tightening in 2007. CoolTouch products are FDA-cleared and are manufactured in Roseville, Calif. For more information: www.cooltouch.com


'/>"/>
SOURCE CoolTouch Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
2. Cynosure Files Patent Infringement Lawsuit Against CoolTouch Inc.
3. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
4. CoolTouch Introduces CoolBlue Duet(TM) Laser Lipolysis Suction Handpiece
5. VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
6. CoolTouch Launches CoolLipo Trio Offering Physicians Three Functions in One
7. Cynosure Obtains Favorable Markman Rulings in Patent Infringement Case Against CoolTouch
8. Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB
9. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
10. Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter
11. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 As interest ... overall health care gains momentum worldwide, Rev. Eric J. ... HealthCare Chaplaincy Network (HCCN), will be the keynote speaker ... care in Israel’s public health system. , The conference, “Hope ...
(Date:1/22/2015)... January 22, 2015 Compare-autoinsurance.org has released a new ... by an auto insurance policy . , Some types ... Clients should check the newly released blog post to see if ... and dangerously damaged vehicles are some of the cars that cannot ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... meat, starches and sweets is linked to a rise ... to a study by US and Chinese researchers released ... the 1990s Shanghai Breast Cancer Study by Vanderbilt University ... between higher incidence of breast cancer and a move ...
... Roche Holding AG says that arthritis drug Actemra has ... helps relieve symptoms of rheumatoid arthritis in difficult-to-treat ... to regulatory approval. ,The Radiate study was conducted ... Actemra was given in combination with a standard treatment ...
... folic acid fortification of enriched grains in the mid 1990s, ... and Canada with neural tube defects has declined by 20 ... institution of fortification, however, the rate at which new cases ... report researchers at the Jean Mayer USDA Human Nutrition Research ...
... hospital ranked as one of Americas Best by U.S. News ... days than those admitted to a non-ranked hospital , according ... of Internal Medicine, one of the JAMA/Archives journals. ... mortality measures that are publicly reported by the Centers for ...
... 9 issue of Archives of Internal Medicine, one of ... screen for prostate cancer are frequently performed among patients ... be beneficial, and clinicians with certain characteristics are more ... ,Most guidelines for clinical practice do not recommend routine ...
... a man of the times, throwing around terms like "eco-design" ... at the Bangkok home he designed for his family two ... only to be energy efficient but to produce energy -- ... of some of the brightest international names working in eco-architecture ...
Cached Medicine News:Health News:Folicacid Fortification Very Beneficial 2Health News:Folicacid Fortification Very Beneficial 3Health News:Americas Best Hospital Reduced Heart Attack Rates 2Health News:Americas Best Hospital Reduced Heart Attack Rates 3Health News:Clinicians Ordering Inappropriate Prostate Screenings 2Health News:Eco-architecture Takes Root in Thailand, but Growth is Slow 2Health News:Eco-architecture Takes Root in Thailand, but Growth is Slow 3
(Date:1/23/2015)... 23, 2015 A lot of discussion in the medical ... certain illnesses, injuries, or conditions. As medical science advances, doctors ... with ones that they consider to be more cutting edge. ... one textbook method of treatment that stands out as the ...
(Date:1/23/2015)... new analysis of Centers for Medicare and Medicaid Services, ... 81 percent of seniors chose lower-cost preferred pharmacy plans ... pharmacies. The findings were released by Drug Channels ... foundation of Medicare Part D," said Pharmaceutical Care Management ...
(Date:1/23/2015)... More than a third of reproductive-aged women enrolled in ... insurance, filled a prescription for an opioid pain medication each ... Morbidity and Mortality Weekly Report (MMWR). Opioids ... to severe pain.  They are also found in some prescription ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... Misonix, Inc. (NASDAQ: MSON ), a ... innovative therapeutic ultrasonic products worldwide for wound debridement, ... other surgical and medical applications, announced its recent ... Advances in Skin and Wound Care held in ...
... GAITHERSBURG, Md., Nov. 1, 2011 /PRNewswire-iReach/ ... specialty pharmaceutical company focused exclusively in the HIV-1 ... DFH an exclusive research license with an option ... maturation inhibitor program.  Maturation inhibitors are a novel ...
Cached Medicine Technology:Misonix Exhibits at 26th Annual Clinical Symposium on Advances in Skin and Wound Care 2Misonix Exhibits at 26th Annual Clinical Symposium on Advances in Skin and Wound Care 3DFH Pharma Obtains Exclusive Rights to Second-Generation HIV Maturation Inhibitor Program 2DFH Pharma Obtains Exclusive Rights to Second-Generation HIV Maturation Inhibitor Program 3DFH Pharma Obtains Exclusive Rights to Second-Generation HIV Maturation Inhibitor Program 4
... has it's temperature set by means ... pressing a button. A green LED ... a flashing amber LED indicates the ... A red LED and an audible ...
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The QuickVue Advance® G. vaginalis test is an enzyme activity test for use in the detection of Gardnerella vaginalis Proline IminoPeptidase(PIP) activity in vaginal fluid specimens from women su...
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: